Cylert
Quick Facts
Pemoline
Date Approved
1975
Manufacturer
Abbott Laboratories
Status
Removed April 24, 2005 Approved Uses
ADHD
Serious Side Effects
Serious Side Effects
Heart attack
Stroke
Sudden death
Liver failure
Liver transplants
Related Topics
Adderall
Concerta
Metadate
Methylin
Ritalin
Strattera
Heart Attack
Stroke
ADHD Drugs
Defective Drugs
Diseases
CLICK HERE TO DOWNLOAD OUR CYLERT INFORMATION PACKAGE
Cylert Side Effects May Link To Liver Failure Lawsuits
Cylert | Lawsuits, Lawyers | Side Effects: Fatality, Liver Failure, Pemoline
On April 24, 2005, Abbott Laboratories Inc. halted sales and removed Cylert, an attention deficit drug from the market after a consumer group complained Cylert was too dangerous. Consumer group Public Citizen charges that Cylert has caused 21 cases of liver failure, including 13 that were fatal or required transplants.
Cylert is a stimulant that was approved to treat attention deficit hyperactivity disorder, or ADHD, in 1975. In 2004 about 117,000 prescriptions for the drug were filled in the United States, according to Public Citizen.
Reports given to the FDA show that at least 193 patients have suffered serious consequences from the drug, said Dr. Peter Lurie, deputy director of the group, Public Citizen. This is an outmoded drug, he said, and there is no reason for it to be still on the market. Generic companies sell copycat versions of the drug under the name Pemoline.
Public Citizen asked the U.S. Food and Drug Administration to ban Cylert and its generic competitors immediately. Generic companies can still sell their versions even after Abbott pulls the medicine, unless the FDA determines the drug was withdrawn for safety reasons. Britain and Canada removed the drug from the market, but the F.D.A. instead twice chose to stiffen warnings on the drug's label, the petition said. In 1996, the agency sent a letter to Abbott saying that the drug's marketing could continue "if and only if a good faith effort is made on your part to collect the data necessary to measure the drug's risks.
The agency suggested that Abbott create a patient registry for this task, the letter stated. But Abbott never created a registry, the petition stated. An F.D.A. analysis concluded that Cylert increased the risk of liver failure almost 17 times, the petition stated. A 2002 agency report found that stiffer label warnings had failed to prompt doctors to increase testing of patients' livers, the petition stated.
Dr. Lurie said Public Citizen had wanted for some time to file a petition about Cylert but was only recently able to complete the task.
Legal Help For Victims Affected By Cylert
If you or a loved one took Cylert and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us at 1-800-LAW-INFO (1-800-529-4636).










